Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Baxter
Julphar
Chinese Patent Office
Teva
Moodys
Fish and Richardson
US Army

Generated: July 17, 2018

DrugPatentWatch Database Preview

Pimozide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for pimozide and what is the scope of pimozide freedom to operate?

Pimozide
is the generic ingredient in two branded drugs marketed by Teva and Par Pharm, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for pimozide. Two suppliers are listed for this compound.
Pharmacology for pimozide
Medical Subject Heading (MeSH) Categories for pimozide
Synonyms for pimozide
062P784
1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one
1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one
1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone
1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine
1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H- benzimidazol-2-one
1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
1-[1-[4,4-Bis(p-flurophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine
1-{1-[4,4-bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one
1-{1-[4,4-Bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Pimozide)
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
117210-EP2272537A2
117210-EP2275420A1
117210-EP2295061A1
117210-EP2298776A1
1HIZ4DL86F
2-Benzimidazolinone, 1-(1-(4,4-bis(p-fluorophenyl)butyl)-4-piperidyl)-
2-Benzimidazolinone, 1-[1-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-
2-Benzimidazolinone,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-
2062-78-4
2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-
2H-Benzimidazol-2-one, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-
2H-Benzimidazol-2-one,1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-
2H-Benzimidazol-2-one,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-
3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one
3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
5-24-02-00367 (Beilstein Handbook Reference)
AB00052215
AB00052215_07
AB00052215_08
AB00052215-06
AC1L27SR
AC1Q4M09
AC1Q4NM9
AKOS024458706
AN-50194
Antalon
AOB5780
API0003851
AS-13916
ASTA Medica Brand of Pimozide
BCBcMAP01_000043
BDBM50334150
BG0381
BIDD:GT0435
BPBio1_000304
BRD-K01292756-001-06-0
BRN 0729089
BSPBio_000276
BSPBio_001439
BSPBio_002941
C07566
C28H29F2N3O
CAS-2062-78-4
CCG-35918
CCG-36461
CCG-39728
CCRIS 9172
CHEBI:8212
CHEMBL1423
CTK8G2428
D00560
D00KHM
DB01100
DivK1c_000386
DSSTox_CID_3474
DSSTox_GSID_23474
DSSTox_RID_77042
DTXSID8023474
EINECS 218-171-7
EU-0100946
FT-0673903
GTPL90
HE324130
HMS1568N18
HMS1791H21
HMS1921H19
HMS1989H21
HMS2089C11
HMS2092F09
HMS2095N18
HMS2231P23
HMS3262N14
HMS3267E19
HMS3370N13
HMS3402H21
HMS501D08
IDI1_000386
J-013477
Janssen Brand of Pimozide
KBio1_000386
KBio2_000925
KBio2_003493
KBio2_006061
KBio3_002441
KBioGR_000720
KBioSS_000925
KS-000018AL
L000494
Lopac-P-1793
Lopac0_000946
LP00946
LS-33236
M828
McN-JR 6238
McN-JR-6238
MFCD00055081
MLS000028410
MLS001077311
MLS002702058
MolPort-001-736-597
N-benzyl-N-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)benzenamine
NCGC00015802-01
NCGC00015802-02
NCGC00015802-03
NCGC00015802-04
NCGC00015802-05
NCGC00015802-06
NCGC00015802-07
NCGC00015802-08
NCGC00015802-09
NCGC00015802-10
NCGC00015802-11
NCGC00015802-12
NCGC00015802-13
NCGC00015802-14
NCGC00015802-15
NCGC00015802-16
NCGC00015802-18
NCGC00016601-01
NCGC00022282-03
NCGC00024888-01
NCGC00024888-02
NCGC00024888-03
NCGC00024888-04
NCGC00024888-05
NCGC00024888-06
NCGC00024888-07
NCGC00255294-01
NCGC00261631-01
NCIMech_000356
NINDS_000386
NSC 170984
NSC-170984
NSC-757854
NSC170984
NSC757854
Opera_ID_1580
Opiran
OR008753
Orap
Orap (TN)
Orap forte
P 1793
Pharmakon1600-01501134
Pharmascience Brand of Pimozide
pimozida
Pimozida [INN-Spanish]
Pimozide (1-[1-[4,4-Bis(4-fluoroohenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidaol-2-one)
Pimozide (JAN/USP/INN)
Pimozide (JP17/USP/INN)
Pimozide [USAN:INN:BAN:JAN]
Pimozide [USAN:USP:INN:BAN:JAN]
Pimozide, European Pharmacopoeia (EP) Reference Standard
Pimozide, United States Pharmacopeia (USP) Reference Standard
PIMOZIDE1-{1-[4,4-BIS-(4-FLUORO-PHENYL)-BUTYL]-PIPERIDIN-4-YL}-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONE
Pimozidum
Pimozidum [INN-Latin]
Prestwick_395
Prestwick0_000308
Prestwick1_000308
Prestwick2_000308
Prestwick3_000308
Primozida
Primozida [INN-Spanish]
Primozide
R 6238
R-6238
SBI-0050920.P003
SCHEMBL41584
SCHEMBL7519553
SMP1_000241
SMR000058385
SPBio_001211
SPBio_002495
Spectrum_000445
SPECTRUM1501134
Spectrum2_001026
Spectrum3_001451
Spectrum4_000420
Spectrum5_001308
SR-01000075392
SR-01000075392-1
Tocris-0937
Tox21_110224
Tox21_110224_1
Tox21_301586
Tox21_500946
UNII-1HIZ4DL86F
WLN: T56 BMVNJ D- DT6NTJ A3YR DF&R DF
YVUQSNJEYSNKRX-UHFFFAOYSA-N
Z241910386
ZINC4175630

US Patents and Regulatory Information for pimozide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva ORAP pimozide TABLET;ORAL 017473-001 Jul 31, 1984 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva ORAP pimozide TABLET;ORAL 017473-003 Aug 27, 1997 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm PIMOZIDE pimozide TABLET;ORAL 204521-002 Sep 28, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm PIMOZIDE pimozide TABLET;ORAL 204521-001 Sep 28, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
McKinsey
US Department of Justice
Deloitte
Cipla
McKesson
AstraZeneca
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.